These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 37985664)
41. Could masks curtail the post-lockdown resurgence of COVID-19 in the US? Ngonghala CN; Iboi EA; Gumel AB Math Biosci; 2020 Nov; 329():108452. PubMed ID: 32818515 [TBL] [Abstract][Full Text] [Related]
42. Comparative assessment of methods for short-term forecasts of COVID-19 hospital admissions in England at the local level. Meakin S; Abbott S; Bosse N; Munday J; Gruson H; Hellewell J; Sherratt K; ; Funk S BMC Med; 2022 Feb; 20(1):86. PubMed ID: 35184736 [TBL] [Abstract][Full Text] [Related]
43. Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021. COVID-19 National Preparedness Collaborators Lancet; 2022 Apr; 399(10334):1489-1512. PubMed ID: 35120592 [TBL] [Abstract][Full Text] [Related]
44. Scenario Design for Infectious Disease Projections: Integrating Concepts from Decision Analysis and Experimental Design. Runge MC; Shea K; Howerton E; Yan K; Hochheiser H; Rosenstrom E; Probert WJM; Borchering R; Marathe MV; Lewis B; Venkatramanan S; Truelove S; Lessler J; Viboud C medRxiv; 2023 Oct; ():. PubMed ID: 37873156 [TBL] [Abstract][Full Text] [Related]
45. Estimated Health Outcomes and Costs of COVID-19 Prophylaxis With Monoclonal Antibodies Among Unvaccinated Household Contacts in the US. Flaxman AD; Issema R; Barnabas RV; Ross JM JAMA Netw Open; 2022 Apr; 5(4):e228632. PubMed ID: 35452104 [TBL] [Abstract][Full Text] [Related]
46. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. GBD 2021 Demographics Collaborators Lancet; 2024 May; 403(10440):1989-2056. PubMed ID: 38484753 [TBL] [Abstract][Full Text] [Related]
47. Projections of global mortality and burden of disease from 2002 to 2030. Mathers CD; Loncar D PLoS Med; 2006 Nov; 3(11):e442. PubMed ID: 17132052 [TBL] [Abstract][Full Text] [Related]
48. PaCAR: COVID-19 Pandemic Control Decision Making via Large-Scale Agent-Based Modeling and Deep Reinforcement Learning. Guo X; Chen P; Liang S; Jiao Z; Li L; Yan J; Huang Y; Liu Y; Fan W Med Decis Making; 2022 Nov; 42(8):1064-1077. PubMed ID: 35775610 [TBL] [Abstract][Full Text] [Related]
49. The Use and Misuse of Mathematical Modeling for Infectious Disease Policymaking: Lessons for the COVID-19 Pandemic. James LP; Salomon JA; Buckee CO; Menzies NA Med Decis Making; 2021 May; 41(4):379-385. PubMed ID: 33535889 [TBL] [Abstract][Full Text] [Related]
50. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis. COVID-19 Cumulative Infection Collaborators Lancet; 2022 Jun; 399(10344):2351-2380. PubMed ID: 35405084 [TBL] [Abstract][Full Text] [Related]
51. How many people is the COVID-19 pandemic pushing into poverty? A long-term forecast to 2050 with alternative scenarios. Moyer JD; Verhagen W; Mapes B; Bohl DK; Xiong Y; Yang V; McNeil K; Solórzano J; Irfan M; Carter C; Hughes BB PLoS One; 2022; 17(7):e0270846. PubMed ID: 35802674 [TBL] [Abstract][Full Text] [Related]
52. Evaluating the Impact of SARS-CoV-2 Variants on the COVID-19 Epidemic and Social Restoration in the United States: A Mathematical Modelling Study. Li R; Li Y; Zou Z; Liu Y; Li X; Zhuang G; Shen M; Zhang L Front Public Health; 2021; 9():801763. PubMed ID: 35083192 [No Abstract] [Full Text] [Related]
53. [Evaluation of Non-Pharmaceutical Interventions for Reducing Contact Rate in COVID-19 Pandemic: R0 Estimation and Modeling for Istanbul]. Maral I; Yaylalı E; Güçlü H; İkiışık H; Güner AE Mikrobiyol Bul; 2021 Jul; 55(3):389-405. PubMed ID: 34416804 [TBL] [Abstract][Full Text] [Related]
54. Modeling COVID-19 scenarios for the United States. IHME COVID-19 Forecasting Team Nat Med; 2021 Jan; 27(1):94-105. PubMed ID: 33097835 [TBL] [Abstract][Full Text] [Related]
55. Forecasting the spread of SARS-CoV-2 is inherently ambiguous given the current state of virus research. Koenen M; Balvert M; Brekelmans R; Fleuren H; Stienen V; Wagenaar J PLoS One; 2021; 16(3):e0245519. PubMed ID: 33657128 [TBL] [Abstract][Full Text] [Related]
56. Leveraging advances in data-driven deep learning methods for hybrid epidemic modeling. Chen S; Janies D; Paul R; Thill JC Epidemics; 2024 Sep; 48():100782. PubMed ID: 38971085 [TBL] [Abstract][Full Text] [Related]
57. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. COVID-19 Mental Disorders Collaborators Lancet; 2021 Nov; 398(10312):1700-1712. PubMed ID: 34634250 [TBL] [Abstract][Full Text] [Related]
58. SARS-CoV-2 transmission in opposition-controlled Northwest Syria: modeling pandemic responses during political conflict. Marzouk M; Alhiraki OA; Aguas R; Gao B; Clapham H; Obaid W; Altaleb H; Almhawish N; Rihawi H; Abbara A; Douedari Y; Hariri M; Howard N; Int J Infect Dis; 2022 Apr; 117():103-115. PubMed ID: 35123027 [TBL] [Abstract][Full Text] [Related]
59. Flexible, Freely Available Stochastic Individual Contact Model for Exploring COVID-19 Intervention and Control Strategies: Development and Simulation. Churches T; Jorm L JMIR Public Health Surveill; 2020 Sep; 6(3):e18965. PubMed ID: 32568729 [TBL] [Abstract][Full Text] [Related]